Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Cell Reports|October 18, 2018
PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF MethylationLok Hei Chan, Lei Zhou, Kai Yu Ng, et al.
Journal of Hepatology|November 19, 2020
Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinomaYu-Hua Huang, Chris Zhi-Yi Zhang, Qun-Sheng Huang, et al.
Gut|June 15, 2022
Escape from cell-cell and cell-matrix adhesion dependence underscores disease progression in gastric cancer organoid modelsYin Tong, Priscilla S W Cheng, Chung Sze Or, et al.
Cancer Research|June 29, 2022
Caspase-3-Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Carmen Oi Ning Leung, Lei Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2020
A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targetsMing Liu, Qian Yan, Yi Sun, et al.
Journal of Hepatology|October 3, 2025
Targeting cell-state plasticity driven by FOXM1/CEBPB axis disrupts developmental heterogeneity and therapeutic resistance in hepatocellular carcinomaXiao-Feng Zhang, Xiao-Yu Zuo, Yun Zhu, et al.
Nature Communications|November 11, 2025
Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinomaMartina Mang Leng Lei, Carmen Oi Ning Leung, Rainbow Wing Hei Leung, et al.
Cell Stem Cell|October 23, 2018
A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic ScreeningHelen H N Yan, Hoi Cheong Siu, Simon Law, et al.
Gut|November 1, 2024
Pharmacological activation of STAT1-GSDME pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinomaYalin Tu, Haoran Wu, Chengpeng Zhong, et al.
Pageof 13